Nicoletta Sacchi

Title: Innovations in Breast Cancer Diagnosis by Nicoletta Sacchi

Introduction

Nicoletta Sacchi is a prominent inventor based in North Potomac, MD (US). She has made significant contributions to the field of medical diagnostics, particularly in breast cancer research. With a total of 3 patents, her work focuses on innovative methods for diagnosing cell proliferative disorders.

Latest Patents

One of her latest patents is titled "Aberrantly methylated genes as markers of breast malignancy." This invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes, including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARβ), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, HIN-1, RASSF1A, and combinations of such genes, serve as markers of breast malignancy.

Career Highlights

Nicoletta Sacchi is affiliated with Johns Hopkins University, where she continues her research and development in the field of cancer diagnostics. Her work has been instrumental in advancing the understanding of genetic markers associated with breast cancer.

Collaborations

Some of her notable coworkers include Saraswati Vaidyanathan Sukumar and William C Dooley. Their collaborative efforts contribute to the innovative research environment at Johns Hopkins University.

Conclusion

Nicoletta Sacchi's contributions to breast cancer diagnostics through her patented inventions highlight the importance of innovation in medical research. Her work not only advances scientific knowledge but also has the potential to improve patient outcomes in breast cancer diagnosis.